Page last updated: 2024-10-25

eflornithine and Cardiomyopathy, Chagas

eflornithine has been researched along with Cardiomyopathy, Chagas in 1 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"Nifurtimox is one of the two molecules used for treatment of Chagas disease."7.77[Nifurtimox, a bright future for treatment of Chagas disease]. ( Beranger, C; Boulliat, C; Coillot, C; Gaillard, K; Oliver, M; Rouault, M; Wolf, A, 2011)
"Nifurtimox is one of the two molecules used for treatment of Chagas disease."3.77[Nifurtimox, a bright future for treatment of Chagas disease]. ( Beranger, C; Boulliat, C; Coillot, C; Gaillard, K; Oliver, M; Rouault, M; Wolf, A, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wolf, A1
Boulliat, C1
Coillot, C1
Rouault, M1
Gaillard, K1
Beranger, C1
Oliver, M1

Other Studies

1 other study available for eflornithine and Cardiomyopathy, Chagas

ArticleYear
[Nifurtimox, a bright future for treatment of Chagas disease].
    Medecine tropicale : revue du Corps de sante colonial, 2011, Volume: 71, Issue:2

    Topics: Chagas Cardiomyopathy; Chagas Disease; Drug Therapy, Combination; Eflornithine; Humans; Nifurtimox;

2011